A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab plus Standard of Care versus Placebo plus Standard of Care in Adult Subjects with Active Lupus Nephritis
Phase of Trial: Phase III
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Belimumab (Primary) ; Azathioprine; Cyclophosphamide; Mycophenolate; Steroids
- Indications Lupus nephritis
- Focus Therapeutic Use
- Acronyms BLISS-LN
- Sponsors GlaxoSmithKline; Human Genome Sciences
- 26 Jan 2017 Planned End Date changed from 1 Sep 2019 to 1 Feb 2020.
- 26 Jan 2017 Planned primary completion date changed from 1 Feb 2019 to 1 Jul 2019.
- 05 Jul 2016 Planned End Date changed from 1 Mar 2019 to 1 Sep 2019.